180 Life Sciences Stockholders Approve Increase in Authorized Shares and Equity Plan Amendments

FORUM MARKETS Inc

• Stockholders approved increase in authorized common stock from 100M to 1B shares on July 24, 2025.
• Fourth Amendment to 2022 Omnibus Incentive Plan approved, raising initial share limit to 5M with annual increases.
• 2025 Option Incentive Plan approved, granting 1M shares in non-qualified stock options.
• Advisory vote on executive compensation and reverse stock split authorization (1:4 to 1:40) also approved.
• Class I directors Lawrence Steinman and Stephen Shoemaker were elected at the annual meeting.